This post is from a suggested group
Transarterial Chemoembolization: A Targeted Approach for Liver Cancer Treatment
Transarterial Chemoembolization (TACE) has emerged as a significant treatment option for patients with liver cancer, particularly those diagnosed with hepatocellular carcinoma (HCC) who are not suitable candidates for surgical resection. TACE is a minimally invasive procedure that combines localized chemotherapy with embolization, aiming to destroy cancer cells while preserving as much healthy liver tissue as possible.
The procedure begins with a catheter being inserted through the femoral artery, which is carefully guided to the hepatic artery supplying blood to the tumor. Once positioned, a mixture of chemotherapeutic agents and embolic materials is injected directly into the tumor’s blood vessels. This dual action both delivers high concentrations of chemotherapy locally and blocks the blood supply to the tumor, effectively starving it of oxygen and nutrients. This targeted approach reduces systemic side effects compared to traditional chemotherapy, making TACE a safer option for…